In a patient with post‑traumatic stress disorder taking mirtazapine (Remeron) 30 mg nightly and prazosin, who reports that nightmares have become more vivid, what dosage adjustments are recommended?

Increase Prazosin Dosage for Persistent PTSD Nightmares

When nightmares become more vivid or realistic on current prazosin dosing, this indicates inadequate alpha-1 adrenergic blockade—you should titrate prazosin upward rather than adjusting mirtazapine. The patient's worsening nightmare quality suggests breakthrough noradrenergic hyperarousal that requires higher prazosin doses to control 1.

Primary Recommendation: Prazosin Dose Escalation

Increase prazosin gradually to achieve therapeutic effect, targeting doses of 10-16 mg nightly (or higher if needed). The American Academy of Sleep Medicine position paper demonstrates that effective prazosin doses in PTSD trials ranged widely—from 1 to 20 mg daily, with mean therapeutic doses of 13-15.6 mg in veterans 1. The current dose is likely subtherapeutic.

Titration Strategy:

• Increase prazosin by 1-2 mg every 3-7 days as tolerated
• Target dose: 10-16 mg at bedtime for most patients (men may require higher doses than women—mean 15.6 mg vs 7.0 mg in active-duty soldiers) 1
• Monitor for orthostatic hypotension after each dose increase, particularly the first dose
• Maximum doses up to 20 mg have been studied in large VA trials, and case reports document safe use up to 30-45 mg in treatment-resistant cases 1, 2

Why Not Increase Mirtazapine?

Mirtazapine at 30 mg is already at a moderate-to-high dose for PTSD, and increasing it further will not specifically target the nightmare pathophysiology. While mirtazapine (a NaSSA) does show evidence for improving overall PTSD symptoms (RR 0.45 for treatment response) 3, it works through serotonergic and histaminergic mechanisms rather than blocking the noradrenergic hyperarousal that drives nightmares 4.

The FDA label for Remeron indicates maximum dosing of 45 mg daily, but the incremental benefit above 30 mg for PTSD nightmares specifically is not established 4. More importantly, higher mirtazapine doses increase sedation, weight gain, and metabolic side effects without addressing the core nightmare mechanism 4.

Critical Evidence About Prazosin

The Nuanced Picture:

The evidence for prazosin is mixed but clinically compelling 1:

• Multiple smaller RCTs showed significant benefit: Reductions in nightmare frequency and severity, with 50-64% of patients showing marked improvement 1
• One large VA trial (304 participants) showed no benefit: Mean dose 14.8 mg showed no difference from placebo at 10 or 26 weeks 1

However, the negative VA trial had a critical confound: 78% of participants were on concurrent antidepressants, which may have blunted prazosin's effect 1. Earlier studies showed decreased prazosin response in patients taking SSRIs concurrently—total CAPS scores decreased by 30.1 points without SSRIs versus only 9.6 points with SSRIs 1.

Clinical Bottom Line:

Despite the mixed evidence, prazosin remains the first-line pharmacologic agent for PTSD nightmares 1, 5. The American Academy of Sleep Medicine Task Force unanimously agreed to downgrade but not eliminate the recommendation, noting "it is clearly apparent to clinicians that many patients respond very well to prazosin and this agent remains the first choice for pharmacologic therapy" 1.

The Mirtazapine-Prazosin Interaction Concern

There may be a pharmacodynamic interaction reducing prazosin efficacy when combined with antidepressants like mirtazapine 1. The guideline explicitly states: "There may be an interaction with antidepressant medications across these various studies which needs to be clarified" 1.

This means:

• Higher prazosin doses may be needed when combined with mirtazapine
• The current prazosin dose is likely insufficient to overcome this interaction
• Increasing prazosin is more rational than increasing mirtazapine

Practical Implementation

Immediate Actions:

1. Check orthostatic vital signs at baseline (sitting and standing BP after 1-3 minutes)
2. Increase prazosin by 2 mg (if tolerating current dose well) or 1 mg (if any dizziness)
3. Recheck orthostatic vitals 2-3 days after each increase
4. Continue titration weekly until nightmares improve or side effects emerge
5. Keep mirtazapine at 30 mg during prazosin titration

Monitoring for Adverse Effects:

• Orthostatic hypotension and dizziness are the primary concerns but are generally transient 1
• No falls or syncopal episodes occurred in most trials even at doses of 13-16 mg 1
• First-dose hypotension: Have patient take first increased dose at bedtime when already lying down

Expected Timeline:

• Nightmare suppression can occur within 1 week of reaching therapeutic dose 6
• Full response may take 2-4 weeks at optimal dosing
• If no response by 15-20 mg, consider alternative agents (topiramate, atypical antipsychotics) 1, 7

Alternative Consideration: Split Dosing

If nightmares persist despite high bedtime dosing, consider adding a morning dose of prazosin 1. The active-duty soldier trial used both bedtime and mid-morning dosing with good effect 1. This addresses daytime hyperarousal symptoms that may be contributing to nightmare intensity.

What If Prazosin Fails at Maximum Doses?

If prazosin remains ineffective at 16-20 mg:

1. Consider topiramate (limited evidence but some RCT support) 1
2. Consider atypical antipsychotics (risperidone, olanzapine, quetiapine) for augmentation 7
3. Refer for trauma-focused psychotherapy (image rehearsal therapy, cognitive behavioral therapy for PTSD) 1
4. Re-evaluate mirtazapine dose only after optimizing prazosin

1, 2, 5, 7